AP2007004156A0 - Composition containing chitosan for sustained drugrelease - Google Patents

Composition containing chitosan for sustained drugrelease

Info

Publication number
AP2007004156A0
AP2007004156A0 AP2007004156A AP2007004156A AP2007004156A0 AP 2007004156 A0 AP2007004156 A0 AP 2007004156A0 AP 2007004156 A AP2007004156 A AP 2007004156A AP 2007004156 A AP2007004156 A AP 2007004156A AP 2007004156 A0 AP2007004156 A0 AP 2007004156A0
Authority
AP
ARIPO
Prior art keywords
drugrelease
sustained
composition containing
containing chitosan
chitosan
Prior art date
Application number
AP2007004156A
Other languages
English (en)
Inventor
Mayyas Mohammed Ahma Al-Remawi
Murshed Ab-Del-Qader Mohammed
Adanan Badwan
Original Assignee
Jordanian Pharmaceutical Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jordanian Pharmaceutical Mfg filed Critical Jordanian Pharmaceutical Mfg
Publication of AP2007004156A0 publication Critical patent/AP2007004156A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AP2007004156A 2005-02-17 2005-12-19 Composition containing chitosan for sustained drugrelease AP2007004156A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05003405A EP1693051B1 (en) 2005-02-17 2005-02-17 Composition containing chitosan for sustained drug release
PCT/EP2005/013663 WO2006087028A1 (en) 2005-02-17 2005-12-19 Composition containing chitosan for sustained drug release

Publications (1)

Publication Number Publication Date
AP2007004156A0 true AP2007004156A0 (en) 2007-10-31

Family

ID=34933799

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2007004156A AP2007004156A0 (en) 2005-02-17 2005-12-19 Composition containing chitosan for sustained drugrelease

Country Status (16)

Country Link
US (1) US20100130612A1 (ja)
EP (2) EP1693051B1 (ja)
JP (1) JP2008530148A (ja)
KR (1) KR20070104643A (ja)
CN (1) CN101128183A (ja)
AP (1) AP2007004156A0 (ja)
AT (1) ATE397439T1 (ja)
AU (1) AU2005327852A1 (ja)
BR (1) BRPI0520078A2 (ja)
CA (1) CA2598364A1 (ja)
DE (1) DE602005007319D1 (ja)
EA (1) EA200701735A1 (ja)
MA (1) MA29317B1 (ja)
TN (1) TNSN07288A1 (ja)
WO (1) WO2006087028A1 (ja)
ZA (1) ZA200706807B (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1955693A1 (en) * 2007-02-09 2008-08-13 The Jordanian Pharmaceutical Manufacturing Co. Composition comprising chitosan and an acidic drug for oral controlled release
EP1955711A1 (en) * 2007-02-09 2008-08-13 The Jordanian Pharmaceutical Manufacturing Co. Composition comprising covalent conjugates of chitosan and an acidic drug for parenteral administration
DE102009024542A1 (de) * 2009-06-10 2010-12-16 Arivine Pharma Ag Zusammensetzungen auf Basis von Chitosan-Oligosacchariden

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8608890A1 (es) * 1985-09-16 1986-09-01 Carulla Vekar S A Preparado farmaceutico liquido a base de teofilina de efec- tos retardados y procedimiento para su obtencion
JPH05339149A (ja) * 1992-02-27 1993-12-21 Taisho Pharmaceut Co Ltd 徐放性懸濁製剤
US5422116A (en) * 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system
JP3605613B2 (ja) * 2001-10-01 2004-12-22 有限会社関西キトサン 植物栽培用液剤
GB0302738D0 (en) * 2003-02-06 2003-03-12 Advanced Biopolymers As Composition

Also Published As

Publication number Publication date
EA200701735A1 (ru) 2008-02-28
EP1693051A1 (en) 2006-08-23
US20100130612A1 (en) 2010-05-27
KR20070104643A (ko) 2007-10-26
ATE397439T1 (de) 2008-06-15
TNSN07288A1 (en) 2008-12-31
DE602005007319D1 (de) 2008-07-17
BRPI0520078A2 (pt) 2009-04-14
WO2006087028A1 (en) 2006-08-24
CN101128183A (zh) 2008-02-20
EP1693051B1 (en) 2008-06-04
CA2598364A1 (en) 2006-08-24
AU2005327852A1 (en) 2006-08-24
JP2008530148A (ja) 2008-08-07
ZA200706807B (en) 2008-10-29
MA29317B1 (fr) 2008-03-03
EP1848397A1 (en) 2007-10-31

Similar Documents

Publication Publication Date Title
IL185906A0 (en) Composition
EP1930012A4 (en) COMPOSITION CONTAINING A CELLO-OLIGOSACCHARIDE
IL184421A0 (en) Fertilizer-compatible composition
GB0522658D0 (en) Composition
AP2008004547A0 (en) Petsticidal compositions
GB0503337D0 (en) Compositions
EP1877042A4 (en) BIOLOGICALLY IMPROVED COMPOSITIONS
EP1865042A4 (en) ANTI-FREEZE COMPOSITION
GB0618435D0 (en) Composition
ZA200705932B (en) Fertilizer-compatible composition
GB0501365D0 (en) Compositions
GB0508250D0 (en) Composition
GB0506044D0 (en) Composition
EP1847249A4 (en) hair dye
IL190321A0 (en) Compositions containing saratin
GB0507167D0 (en) Composition
EP1947129A4 (en) PHOTORADIC AND PHOTOCYSTIC CURING COMPOSITION
EP1864573A4 (en) AGRICULTURAL CHEMICAL COMPOSITION
ZA200707917B (en) Composition
GB0502341D0 (en) Composition
AP2007004156A0 (en) Composition containing chitosan for sustained drugrelease
GB0513641D0 (en) Anti-egeing composition
GB0510286D0 (en) Composition
GB0501364D0 (en) Compositions
GB0525860D0 (en) Composition